CREBBP and neurodegenerative disease: Our results also shed new light on neurologic and psychiatric conditions in which a defective or reduced CBP activity has been reported and plasticity mechanisms are compromised, such as RSTS, substance use disorders, several neurodegenerative diseases, and aging-related cognitive impairments.